| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | RhoGAP | 8.97e-03 | 62 | 43 | 2 | SM00324 | |
| Domain | RhoGAP | 9.25e-03 | 63 | 43 | 2 | PF00620 | |
| Domain | RHOGAP | 9.54e-03 | 64 | 43 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 9.54e-03 | 64 | 43 | 2 | IPR000198 | |
| Domain | - | 9.54e-03 | 64 | 43 | 2 | 1.10.555.10 | |
| Domain | USP_CS | 1.01e-02 | 66 | 43 | 2 | IPR018200 | |
| Domain | USP_1 | 1.13e-02 | 70 | 43 | 2 | PS00972 | |
| Domain | UCH | 1.16e-02 | 71 | 43 | 2 | PF00443 | |
| Domain | USP_2 | 1.16e-02 | 71 | 43 | 2 | PS00973 | |
| Domain | USP_3 | 1.20e-02 | 72 | 43 | 2 | PS50235 | |
| Domain | USP_dom | 1.20e-02 | 72 | 43 | 2 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.20e-02 | 72 | 43 | 2 | IPR001394 | |
| Pubmed | Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases. | 1.03e-05 | 4 | 46 | 2 | 23474714 | |
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 1.15e-05 | 223 | 46 | 5 | 33187986 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 17171436 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 16059920 | ||
| Pubmed | USP4 Auto-Deubiquitylation Promotes Homologous Recombination. | 4.77e-05 | 8 | 46 | 2 | 26455393 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.62e-05 | 774 | 46 | 7 | 15302935 | |
| Pubmed | 9.34e-05 | 11 | 46 | 2 | 19270065 | ||
| Pubmed | 1.02e-04 | 183 | 46 | 4 | 36129980 | ||
| Pubmed | 1.32e-04 | 13 | 46 | 2 | 27833851 | ||
| Pubmed | 1.60e-04 | 79 | 46 | 3 | 27325702 | ||
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 1.78e-04 | 15 | 46 | 2 | 9827704 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.78e-04 | 15 | 46 | 2 | 16824795 | |
| Pubmed | 1.78e-04 | 15 | 46 | 2 | 11318611 | ||
| Pubmed | 1.98e-04 | 407 | 46 | 5 | 12693553 | ||
| Pubmed | 2.03e-04 | 16 | 46 | 2 | 19576224 | ||
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 2.58e-04 | 18 | 46 | 2 | 33108146 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.83e-04 | 440 | 46 | 5 | 34244565 | |
| Pubmed | Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis. | 3.54e-04 | 21 | 46 | 2 | 30179224 | |
| Pubmed | 3.54e-04 | 21 | 46 | 2 | 20708005 | ||
| Pubmed | 3.89e-04 | 22 | 46 | 2 | 34799561 | ||
| Pubmed | CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling. | 4.01e-04 | 108 | 46 | 3 | 30166453 | |
| Pubmed | TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14. | 4.25e-04 | 23 | 46 | 2 | 29581427 | |
| Pubmed | OTUB1 modulates c-IAP1 stability to regulate signalling pathways. | 4.64e-04 | 24 | 46 | 2 | 23524849 | |
| Pubmed | 4.64e-04 | 24 | 46 | 2 | 34983926 | ||
| Pubmed | 5.04e-04 | 25 | 46 | 2 | 12522145 | ||
| Pubmed | 5.22e-04 | 503 | 46 | 5 | 16964243 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 5.46e-04 | 120 | 46 | 3 | 31413325 | |
| Pubmed | 6.16e-04 | 1116 | 46 | 7 | 31753913 | ||
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 8.28e-04 | 32 | 46 | 2 | 22424883 | |
| Pubmed | Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin. | 8.80e-04 | 33 | 46 | 2 | 30323974 | |
| Pubmed | 9.83e-04 | 147 | 46 | 3 | 29576527 | ||
| Cytoband | 1q25 | 3.14e-04 | 26 | 46 | 2 | 1q25 | |
| Cytoband | 10q11.23 | 5.08e-04 | 33 | 46 | 2 | 10q11.23 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.31e-04 | 13 | 24 | 2 | 685 | |
| GeneFamily | Cadherin related | 2.27e-04 | 17 | 24 | 2 | 24 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.99e-03 | 50 | 24 | 2 | 721 | |
| GeneFamily | Ubiquitin specific peptidases | 2.49e-03 | 56 | 24 | 2 | 366 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#2_top-relative-expression-ranked_500 | 1.32e-06 | 166 | 45 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-05 | 176 | 46 | 4 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.25e-05 | 176 | 46 | 4 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 177 | 46 | 4 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-05 | 177 | 46 | 4 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 178 | 46 | 4 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.47e-05 | 179 | 46 | 4 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.47e-05 | 179 | 46 | 4 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.47e-05 | 179 | 46 | 4 | 140dd7dbac48f5f07279f31bf971d7fbd41fa18b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.62e-05 | 181 | 46 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 181 | 46 | 4 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 183 | 46 | 4 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 185 | 46 | 4 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 5.04e-05 | 197 | 46 | 4 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 5.14e-05 | 198 | 46 | 4 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.24e-05 | 199 | 46 | 4 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| Computational | Neighborhood of AQP4 | 1.48e-04 | 45 | 25 | 3 | GCM_AQP4 | |
| Computational | Neighborhood of IL6ST | 2.69e-04 | 55 | 25 | 3 | GCM_IL6ST | |
| Computational | Neighborhood of RAB10 | 6.71e-04 | 176 | 25 | 4 | GCM_RAB10 | |
| Disease | cerebrospinal fluid biomarker measurement, monocyte chemotactic protein 1 measurement | 2.96e-05 | 6 | 42 | 2 | EFO_0006794, EFO_0010596 | |
| Disease | medial orbital frontal cortex volume measurement | 5.81e-04 | 25 | 42 | 2 | EFO_0010315 | |
| Disease | bitter beverage consumption measurement | 1.64e-03 | 42 | 42 | 2 | EFO_0010089 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 1.97e-03 | 46 | 42 | 2 | EFO_0005325, HP_0012735 | |
| Disease | non-alcoholic fatty liver disease, cirrhosis of liver | 2.60e-03 | 53 | 42 | 2 | EFO_0001422, EFO_0003095 | |
| Disease | colon cancer (is_marker_for) | 3.21e-03 | 59 | 42 | 2 | DOID:219 (is_marker_for) | |
| Disease | cognitive function measurement | 3.82e-03 | 1434 | 42 | 7 | EFO_0008354 | |
| Disease | Epstein-Barr virus infection | 4.00e-03 | 66 | 42 | 2 | EFO_0000769 | |
| Disease | radiation-induced disorder | 4.12e-03 | 67 | 42 | 2 | EFO_0009565 | |
| Disease | serum IgG glycosylation measurement | 6.41e-03 | 523 | 42 | 4 | EFO_0005193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEDSNSEPNVDLENQ | 21 | P61201 | |
| QDIQQLSSEENDHPF | 6 | P07307 | |
| EDSNEQPDSLVDHNK | 121 | Q13111 | |
| QQQHSENKRENSEDP | 506 | Q7Z478 | |
| TDASVNSEHFNQNEP | 1446 | Q96F81 | |
| ETSAKNPNDNDHVEA | 176 | Q9H082 | |
| SLDESEDEIQHQTPN | 606 | O60890 | |
| QHQSEGNPDKSEESQ | 136 | Q9P127 | |
| PTENEHDEHDENNAE | 481 | P35241 | |
| PEDDSNTANHNLEQV | 116 | O60840 | |
| DQESSEENSLNSHPE | 831 | Q9BZQ6 | |
| VAEEEDDNNNNHRPP | 431 | O14782 | |
| EDVNDNSPQCITEHN | 916 | Q9NYQ8 | |
| NIDRSPQNDDHSDTD | 186 | Q86W56 | |
| PQNDDHSDTDSEENR | 191 | Q86W56 | |
| QPDQQQDHETTDSSP | 341 | P09848 | |
| HDQQLEEEQSPSDNS | 251 | A6NMN3 | |
| EDQNDHSPSFQDELI | 1501 | Q6V1P9 | |
| PKESEQDVEDSQNHT | 46 | Q8N8J7 | |
| SNNAELQHEDESVPE | 666 | Q5VVM6 | |
| SNSQENVEASHPSQD | 566 | Q02410 | |
| ESQDSEVNFDNSIHP | 81 | O14682 | |
| HQSNDTDSSHDPQEE | 351 | Q15007 | |
| VRDQDHPDGQENDST | 321 | A1Z1Q3 | |
| ADTEQQDHTSPNEND | 236 | Q9UBD0 | |
| AENVADKNEEPSSNH | 221 | Q6P4E1 | |
| LNESDEQHQENEGTN | 261 | Q15545 | |
| VDEQSESLQNTHDDS | 556 | Q6ZRF8 | |
| ENPLADDQSNHDINS | 561 | Q7Z6B7 | |
| DENLKEDPSSQHQEA | 496 | Q8IVB4 | |
| EDPSSQHQEANNLDK | 501 | Q8IVB4 | |
| QHLSENEPVDTNSDN | 506 | O60934 | |
| ADQQPENHEVDTSVS | 226 | A6NDU8 | |
| HDDQEDISPSLAEQQ | 661 | Q9HCL2 | |
| NEDNSQFKDHPTLND | 446 | Q86UE8 | |
| GKEESQHQQPDDSNN | 96 | Q8NA66 | |
| NPDHNEVPNNETTDN | 481 | Q9H2G4 | |
| EEDTNGESHVPQENE | 731 | Q9BZQ8 | |
| SSDLNENQHPLDFDE | 26 | Q9GZP7 | |
| SQDQELPSENENSQS | 666 | Q9Y4E8 | |
| EHENKSDSENEQPAS | 161 | Q9P273 | |
| SNGPKNHSVNEEEQE | 556 | Q14694 | |
| KDDQSQHNSDEEPES | 466 | Q8N3L3 | |
| QHNSDEEPESNVSVD | 471 | Q8N3L3 | |
| PDTENEQYHSDEQND | 461 | Q6S5H5 | |
| PDTENEQYHSDEQND | 461 | A6NI47 | |
| NNTSQERQTEHSPED | 271 | O43164 | |
| EHENDDDTNQSATLN | 1991 | O95071 | |
| TVDAHQLDNQSQPRD | 1186 | Q5VU43 |